Soleno Therapeutics Faces Investigation After Disappointing Drug Launch Metrics

Redwood City, Friday, 16 January 2026.
Soleno shares plummeted following allegations of misleading VYKAT XR launch metrics. Investigations now probe claims that data was manipulated by a controversial physician, raising serious concerns for investors.